USPTO Examiner BONAPARTE AMY C - Art Unit 1692

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
19197151SYNTHESIS OF NOVEL VANADIUM ALKYLIDYNE COMPLEXES AND THEIR USE IN METATHESIS REACTIONSMay 2025November 2025Allow711YesNo
18877886UREA PRODUCTION WITH REDUCED UREA LOSSESDecember 2024September 2025Allow920NoNo
18947046NEW CRYSTALLINE FORM OF L-SERINE AND PROCESS OF PREPARING SAMENovember 2024January 2026Allow1421NoNo
18896739DEVICE AND PROCESS FOR PREPARING SEBACIC ACID THROUGH ELECTROMAGNETIC INDUCTION HEATING COUPLED WITH DRY CONSTANT-TEMPERATURE ALKALINE HYDROLYSISSeptember 2024January 2025Allow410NoNo
18765881PROCESSES FOR THE PREPARATION OF DEUTERATED D-SERINEJuly 2024September 2025Allow1410NoNo
18742992SULFINYLAMINOBENZAMIDE AND SULFONYLAMINOBENZAMIDE DERIVATIVESJune 2024December 2025Allow1811NoNo
18741674PRODRUGS OF STAT3 INHIBITORSJune 2024August 2025Allow1410NoNo
18716802LOW BIURET UREA PRODUCTIONJune 2024February 2025Allow810NoNo
18676957METHODS OF SYNTHESIZING 4-VALYLOXYBUTYRIC ACIDMay 2024December 2025Allow1911NoNo
18650059GluN2C/D Subunit Selective Antagonists of the N-Methyl-D-Aspartate ReceptorApril 2024April 2025Allow1210YesNo
18636199METHODS FOR REMOVAL OF SULFUR DIOXIDE (SO2) FROM TRIFLUOROACETYL CHLORIDE (TFAC)April 2024March 2026Allow2321YesNo
18628186METHODS FOR THE PURIFICATION OF L-GLUFOSINATEApril 2024July 2025Abandon1610NoNo
18625045SYNTHESIS OF TETRAHYDRONAPHTHALENOLS AND USES THEREOFApril 2024August 2025Abandon1610NoNo
18409063PROCESS OF MAKING 3-(4'-AMINOPHENYL)-2-METHOXYPROPIONIC ACID, AND ANALOGS AND INTERMEDIATES THEREOFJanuary 2024August 2025Allow1910YesNo
18378221CATHEPSIN INHIBITORSOctober 2023March 2025Allow1710YesNo
18368410PROSTACYCLIN COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOFSeptember 2023December 2025Abandon2720NoNo
18454685CHEMICAL DERIVATIVES AND METHODS FOR SYNTHESIZING AND COMPOUNDING CHEMICAL DERIVATIVES RELATED TO CAPSAICIN PALMITATE AND CAPSAICIN PRODRUGSAugust 2023March 2025Allow1910YesNo
18365543LOW HALIDE LANTHANUM PRECURSORS FOR VAPOR DEPOSITIONAugust 2023March 2026Allow3220NoYes
18353107DIAMINE COMPOSITION, AND METHOD OF PREPARING DIISOCYANATE COMPOSITIONJuly 2023August 2025Allow2531YesNo
18349727CHEMOSELECTIVE THIOL-CONJUGATION WITH ALKENE OR ALKYNE-PHOSPHONAMIDATESJuly 2023August 2024Allow1310NoNo
18338435Process for preparing {6-[(diethylamino)methyl]naphthalen-2-yl}methyl [4-(hydroxycarbamoyl)phenyl]carbamate having high purityJune 2023December 2025Allow3020NoNo
18212456NOVEL PHOTOCLEAVABLE MASS-TAGS FOR MULTIPLEXED MASS SPECTROMETRIC IMAGING OF TISSUES USING BIOMOLECULAR PROBESJune 2023September 2024Allow1500YesNo
18317768GENERATION OF PEROXYFORMIC ACID THROUGH POLYHYDRIC ALCOHOL FORMATEMay 2023June 2025Allow2540YesNo
18141994UREA SYNTHESIS FROM GREENHOUSE GAS AND NITROGEN VIA TRANSITION METAL-FREE CATALYSIS OVER GRAPHITIC CARBON NITRIDEMay 2023June 2025Abandon2650NoNo
18299605Method for Preparing L-GlufosinateApril 2023October 2024Abandon1810NoNo
18029435PLASTICIZER COMPOSITION AND RESIN COMPOSITION COMPRISING THE SAMEMarch 2023August 2025Allow2900NoNo
18245317PROCESS FOR ACID HYDROLYSIS OF PURE POLYLAUROLACTAMMarch 2023May 2025Allow2600NoNo
18043268METHOD FOR PREPARING GUANIDINO ACETIC ACIDFebruary 2023May 2025Allow2610YesNo
18106305Inhibitors of Dihydroceramide Desaturase For Treating DiseaseFebruary 2023October 2024Allow2111NoNo
18106073OXYSTEROLS AND METHODS OF USE THEREOFFebruary 2023August 2024Allow1810NoNo
18094459Method for Preparation of N-Acetyl Cysteine Amide and Derivatives ThereofJanuary 2023January 2026Allow3720NoNo
18067293CONTINUOUS-FLOW SYNTHESIS METHOD OF 13C-UREADecember 2022May 2025Abandon2940NoNo
18002164PROCESS FOR MANUFACTURING AMINOUNDECANOIC ACID AND AMINODECANOIC ACIDDecember 2022July 2025Allow3110NoNo
18008828A PROCESS FOR THE PURIFICATION OF (R)-2-AMINO-3-PHENYLPROPYL CARBAMATEDecember 2022October 2025Allow3421NoNo
17925331PROCESS, REACTION MIXTURE AND CATALYST FOR THE PRODUCTION OF PHOSGENENovember 2022January 2026Allow3811NoNo
17921139COMPOUND, ANTI-REFLECTIVE FILM INCLUDING SAME, AND DISPLAY DEVICEOctober 2022February 2026Allow4020NoNo
17996957METHOD FOR PRODUCING ESTERS OF HOMOVANILLIC ACIDOctober 2022February 2026Allow3910YesNo
17938884CRYSTAL FORM OF L-GLUFOSINATE AND PREPARATION METHOD AND USE THEREOFOctober 2022January 2026Allow3911NoNo
17916745Process for Producing Acetic AcidOctober 2022January 2026Allow3910NoNo
17914519METHOD FOR THE SYNTHESIS OF ISOCYANATESSeptember 2022October 2025Allow3710YesNo
17911886METHOD OF PREPARING A THIOMETHYLPHENOL DERIVATIVESeptember 2022August 2025Allow3510NoNo
17932441METHOD FOR PRODUCING ISOBUTYLENE, METHOD FOR PRODUCING METHACRYLIC ACID, AND METHOD FOR PRODUCING METHYL METHACRYLATESeptember 2022November 2025Allow3810NoNo
17910859POLYSUBSTITUTED SELENIUM-CONTAINING CYCLOPENT(HEX)ENE SKELETON DERIVATIVE AND SYNTHESIS METHOD THEREOFSeptember 2022August 2025Allow3510NoNo
17909448METHOD AND DEVICE FOR PURIFYING VISCOUS AND/OR SOLID ISOCYANATES FROM A PRODUCT FLOW FROM ISOCYANATE SYNTHESISSeptember 2022January 2026Abandon4110NoNo
17798840PROCESS FOR THE SYNTHESIS OF S-BEFLUBUTAMID USING ASYMMETRIC HYDROGENATIONAugust 2022September 2025Abandon3710NoNo
17798852PROCESS FOR PREPARING S-BEFLUBUTAMID BY RESOLVING 2-BROMOBUTANOIC ACIDAugust 2022December 2025Abandon4010NoNo
17796765Processes for Producing Alkyl Salicylic Acids and Overbased Detergents Derived TherefromAugust 2022January 2026Abandon4101NoNo
17794922IGF2BP2 INHIBITORS AND USES THEREOFJuly 2022November 2025Allow4011NoNo
17758707METHOD FOR PRODUCING GLYCOLIC ACID SALT AND METHOD FOR PRODUCING GLYCOLIC ACIDJuly 2022January 2026Abandon4210NoNo
17861622VINYLETHER COMPOUNDS AND PROCESSES FOR PREPARING ALDEHYDE COMPOUNDS AND A CARBOXYLATE COMPOUND THEREFROMJuly 2022July 2025Allow3611YesNo
17791545OPTIMIZED DEPOLYMERIZATION PROCESS BY GLYCOLYSIS OF A POLYESTER COMPRISING POLYETHYLENE TEREPHTHALTEJuly 2022July 2025Allow3620NoNo
17846492Compounds, Compositions and Methods for the Treatment of CREB-dependent DiseasesJune 2022February 2026Abandon4410YesNo
17784533METHOD FOR THE INDUSTRIAL PREPARATION OF THE DISODIUM SALT OF ((2S)-3-([1,1'-BIPHENYL]-4-YL)-2-((HYDROXY((1R)-1-(((1-(ISOBUTYRYLOXY)ETHOXY)CARBONYL)AMINO)ETHYL)PHOSPHORYL) METHYL)PROPANOYL)-L-ALANINEJune 2022March 2025Allow3400NoNo
17784520METHOD FOR THE UTILIZATION OF CONSTITUENTS FROM BLENDED TEXTILE WASTESJune 2022September 2025Allow4010NoNo
17782697METHOD FOR PRODUCING N-VINYLACETAMIDE AND PYROLYSIS DEVICEJune 2022November 2025Allow4120NoNo
17825689PROCESS FOR THE SYNTHESIS OF CALEBIN-A AND ITS INTERMEDIATESMay 2022October 2024Allow2910NoNo
17778751NOVEL BORON COMPOUND AND ORGANIC LIGHT-EMITTING DIODE COMPRISING SAMEMay 2022November 2025Allow4220NoNo
17777646METHOD FOR PRODUCING ISOCYANATEMay 2022October 2025Abandon4101NoNo
17738607INTEGRATED PROCESS FOR GENERATING ACID ANHYDRIDESMay 2022January 2026Allow4531NoNo
17433700METHOD FOR PROCESSING BENZENE POLYCARBOXYLIC ACID ESTERS AND USE OF SAME TO PRODUCE CYCLOHEXANE POLYCARBOXYLIC ACID ESTERSApril 2022June 2025Allow4510YesNo
17730768METHOD FOR MANUFACTURING FLUOROACETIC ACID ESTERApril 2022November 2025Abandon4331YesNo
17755315LONG-CHAIN COMPOSITION, LONG-CHAIN COMPOSITION SET, ITS PREPARATION AND APPLICATION THEREOFApril 2022December 2025Allow4411YesNo
17771433METHOD FOR PRODUCING BINAPHTHYL CARBOXYLIC ACIDApril 2022February 2026Allow4620YesNo
17724969ANTI-FUNGALS TARGETING THE SYNTHESIS OF FUNGAL SHINGOLIPIDSApril 2022October 2024Abandon3021NoNo
17766084PROCESS FOR MANUFACTURING ALKANESULFONIC ACIDSApril 2022July 2025Allow3910NoNo
17761808ACIDIC ELIMINATION FOR BIO-BASED AROMATICSMarch 2022July 2025Allow4050YesNo
17760716METHOD FOR PRODUCING CONCENTRATED CARBONATE AQUEOUS SOLUTIONMarch 2022January 2026Abandon4620NoNo
17693620INHIBITOR OF EIF2alpha DEPHOSPHORYLATIONMarch 2022June 2025Allow3910NoNo
17642723Formic acid formation from a carbon dioxide sourceMarch 2022October 2025Abandon4310NoNo
17753684TRITERPENOID COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR USE FOR TREATING A NUCLEAR RECEPTOR SUBFAMILY 4 GROUP A MEMBER 1-MEDIATED DISEASEMarch 2022November 2025Allow4421NoNo
17640722METHOD OF MANUFACTURING DIESTER-BASED COMPOUNDMarch 2022September 2025Allow4320YesNo
17640652METHOD OF PREPARING DIESTER-BASED MATERIALMarch 2022October 2025Allow4420YesNo
17639122AN N,N-DIHYDROCARBONYLAMIDE CARBOXYLIC ACID, PREPARATION METHOD THEREFOR AND USE THEREOFMarch 2022May 2025Allow3801YesNo
17634703PREPARATION METHOD OF 3-MERCAPTOPROPIONIC ACIDFebruary 2022July 2025Allow4120NoNo
17631769NITRILOTRIACETIC ACID-CONTAINING LIPIDOID NANOPARTICLESJanuary 2022August 2025Allow4311YesNo
17580657METHOD OF PRODUCING CARBONYL COMPOUND AND FLOW TYPE REACTION SYSTEM OF PRODUCING CARBONYL COMPOUNDJanuary 2022February 2026Allow4930YesNo
17627626METHOD FOR PRODUCING ALPHA-ACYLOXYCARBOXYLIC ACID ESTERJanuary 2022April 2025Allow3910NoNo
17623723NEW STABLE FORMULATIONS OF 1-Z-BROMOALK-1-ENE COMPOUNDS AND USE THEREOF IN THE MANUFACTURE OF PHEROMONESDecember 2021December 2024Allow3600NoNo
17622834METHOD FOR RACEMIC PREPARATION OF CHIRAL B-AMINO ACIDS AND DERIVATIVES THEREOFDecember 2021April 2025Abandon3940NoNo
17618107NEW QUATERNARY AMMONIUM COMPOUNDSDecember 2021September 2025Allow4521NoNo
17596381PROCESS FOR THE PRODUCTION OF DIACYL PEROXIDESDecember 2021September 2024Allow3300YesNo
17526759METHOD FOR PRODUCING SOLID UREA BY GRANULATIONNovember 2021May 2025Allow4231NoNo
17438915PROCESS AND APPARATUS FOR UREA PRODUCTIONSeptember 2021December 2024Allow3901YesNo
17438091METHODS FOR FUNCTIONALIZATION HYDROCARBONSSeptember 2021May 2025Allow4421YesNo
17435831LIGANDS FOR PRODUCTION OF 1-OCTENE IN CHROMIUM ASSISTED ETHYLENE OLIGOMERIZATION PROCESSSeptember 2021June 2025Allow4521YesNo
17435731Process for preparing {6-[(diethylamino)methyl]naphthalen-2-yl}methyl [4-(hydroxycarbamoyl)phenyl]carbamate having high puritySeptember 2021August 2024Allow3521YesNo
17182413PHENOXY CARBOXYLIC ACID COMPOUNDS AND MEDICAL USES THEREOFAugust 2021March 2025Allow4911YesNo
17378958POLYOL-BASED ESTERS OF HYDROXYCARBOXYLIC ACIDSJuly 2021July 2025Allow4830NoNo
17423273AGENT FOR INITIATING A RADICAL ADDITION REACTION AND PROCESS USING ITJuly 2021May 2025Allow4630NoNo
17420886SALT-FREE PRODUCTION OF METHIONINE FROM METHIONINE NITRILEJuly 2021August 2024Allow3710YesNo
17420028PROCESS FOR THE PRODUCTION OF UREA FORMALDEHYDE CONCENTRATEJune 2021July 2025Allow4930NoNo
17420009Synthesis Method for Candesartan Cilexetil IntermediateJune 2021November 2025Abandon5240NoNo
17418636COMPOUND, (CO)POLYMER, COMPOSITION, METHOD FOR FORMING PATTERN, AND METHOD FOR PRODUCING COMPOUNDJune 2021July 2025Allow4931YesNo
17357061METHOD FOR PRODUCING FLUOROALKOXIDEJune 2021March 2025Allow4551YesNo
17417599COMPOSITION FOR PRODUCING N-VINYL CARBOXYLIC ACID AMIDEJune 2021October 2024Allow4020YesNo
17416489A process for preparation of amides and esters of 2-((2-hydroxypropanoyl)oxy)propanoic acidJune 2021May 2025Allow4640NoNo
17415271PREPARATION OF A LYSINATE COMPOUND FROM AN AQUEOUS LYSINE SOLUTIONJune 2021June 2025Allow4831NoNo
17414995OXIDATIVE PREPARATION OF MALEIC ACIDJune 2021July 2024Allow3720NoNo
17413540METHOD FOR PRODUCING METHIONINEJune 2021August 2024Allow3820YesNo
17298477FLUORESCENT PROBE FOR DETECTING CARBOXYPEPTIDASE ACTIVITYMay 2021September 2024Allow3910YesNo

Appeals Overview

No appeal data available for this record. This may indicate that no appeals have been filed or decided for applications in this dataset.

Examiner BONAPARTE, AMY C - Prosecution Strategy Guide

Executive Summary

Examiner BONAPARTE, AMY C works in Art Unit 1692 and has examined 43 patent applications in our dataset. With an allowance rate of 88.4%, this examiner has an above-average tendency to allow applications. Applications typically reach final disposition in approximately 42 months.

Allowance Patterns

Examiner BONAPARTE, AMY C's allowance rate of 88.4% places them in the 69% percentile among all USPTO examiners. This examiner has an above-average tendency to allow applications.

Office Action Patterns

On average, applications examined by BONAPARTE, AMY C receive 2.00 office actions before reaching final disposition. This places the examiner in the 50% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by BONAPARTE, AMY C is 42 months. This places the examiner in the 18% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a +14.5% benefit to allowance rate for applications examined by BONAPARTE, AMY C. This interview benefit is in the 53% percentile among all examiners. Recommendation: Interviews provide an above-average benefit with this examiner and are worth considering.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 37.9% of applications are subsequently allowed. This success rate is in the 87% percentile among all examiners. Strategic Insight: RCEs are highly effective with this examiner compared to others. If you receive a final rejection, filing an RCE with substantive amendments or arguments has a strong likelihood of success.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 35.0% of cases where such amendments are filed. This entry rate is in the 52% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.

Petition Practice

When applicants file petitions regarding this examiner's actions, 100.0% are granted (fully or in part). This grant rate is in the 90% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 3% percentile). This examiner rarely makes examiner's amendments compared to other examiners. You should expect to make all necessary claim amendments yourself through formal amendment practice.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 5.3% of allowed cases (in the 81% percentile). Per MPEP § 714.14, a Quayle action indicates that all claims are allowable but formal matters remain. This examiner frequently uses Quayle actions compared to other examiners, which is a positive indicator that once substantive issues are resolved, allowance follows quickly.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • RCEs are effective: This examiner has a high allowance rate after RCE compared to others. If you receive a final rejection and have substantive amendments or arguments, an RCE is likely to be successful.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.